The Cancer Registry becomes part of the NHIS

The information database for individuals with malignant neoplasms and carcinoma in situ will be established as a functional component of the National Health Information System (NHIS), whose primary objective is the systematic collection, storage, analysis, interpretation, and public presentation of information regarding affected patients. This is stipulated by the amendments to the “Medical Oncology” standard, published today in the “State Gazette”.

The new database will be structured into separate sections, including patient information, characteristics of the oncological disease, the treatment applied, the course of the disease, and the assessment of the therapeutic response. Its content is aligned with the requirements and indicators used by Eurostat for the collection and analysis of statistical data. All healthcare facilities in the country performing diagnostic and therapeutic activities for patients with malignant neoplasms and carcinoma in situ will submit the regulated information for the respective sections to the NHIS.

The collection, processing, and analysis of data will be carried out under the terms and procedures established in the Ordinance on the Functioning of the NHIS, which is designed to allow for phased expansion through new modules and functionalities.

Simultaneously, the system will provide the capability to extract aggregated data from the information base for the purpose of assessing and analyzing oncological morbidity. The results obtained will support the formulation of management decisions in the field of prevention and treatment of oncological diseases, with the generated information being in a depersonalized form. It is also planned to supplement existing nomenclatures within the NHIS, as well as in the information systems of healthcare facilities and the National Health Insurance Fund.